| Amanda Halter, | |
|
223 N Locust St, Adrian, MI 49221-2824 | |
| (517) 759-2198 | |
| Not Available |
| Full Name | Amanda Halter |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 223 N Locust St, Adrian, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285182667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 4703096928 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Halter, 223 N Locust St, Adrian, MI 49221-2824 Ph: (517) 759-2198 | Amanda Halter, 223 N Locust St, Adrian, MI 49221-2824 Ph: (517) 759-2198 |
News Archive
Americord Registry, a private cord blood, cord tissue, and placenta tissue banking company, announced today that it is introducing a new policy for client reimbursement. Starting immediately, Americord will offer full reimbursements for cancellation fees that are often incurred by parents who sign up with other cord blood banks.
A new body to ensure NHS IT helps deliver better care and supports the Government's top priority of putting the interests of patients first was announced today by Health Minister John Hutton.
Agenus Inc., a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, today announced results published from a Phase 2 study demonstrated that more than 90% of the patients treated with Prophage Series G-200 were alive at six months after surgery and 30% were alive at twelve months.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Patent and Trademark Office (USPTO) has issued AcelRx two Notices of Allowance for the patent applications entitled "Small-Volume Oral Transmucosal Dosage Forms" and "Bioadhesive Drug Formulations for Oral Transmucosal Delivery."
DySIS Medical Ltd, the medical devices company in female health, announces that the National Institute for Health and Clinical Excellence (‘NICE') has today published positive diagnostics guidance recommending its DySIS cervical cancer screening product to be considered in procurement plans.
› Verified 3 days ago
Donna Lomas, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1040 S Winter St, Adrian, MI 49221 Phone: 517-263-8905 | |
Sonya A Kelley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1040 S Winter St, Adrian, MI 49221 Phone: 517-263-8905 |